Overactive bladder is characterized by urinary urgency with or without urge incontinence, increased daytime frequency, and nocturia. It affects up to 16% of adults.
Oxybutynin is an anticholinergic or beta-3 agonist used to treat overactive bladder by reducing urinary urgency and frequency.
Solifenacin is an anticholinergic or beta-3 agonist used to treat overactive bladder by reducing urinary urgency and frequency.
Mirabegron is an anticholinergic or beta-3 agonist used to treat overactive bladder by reducing urinary urgency and frequency.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: